The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline
Abstract
PURPOSE: To provide guidance on the use of opioids to manage pain from cancer or cancer treatment in adults. METHODS: A systematic review of the literature identified systematic reviews and randomized controlled trials of the efficacy and safety of opioid analgesics in people with cancer, approaches to opioid initiation and titration, and the prevention and management of opioid adverse events. PubMed and the Cochrane Library were searched from January 1, 2010, to February 17, 2022. American Society of Clinical Oncology convened an Expert Panel to review the evidence and formulate recommendations. RESULTS: The evidence base consisted of 31 systematic reviews and 16 randomized controlled trials. Opioids have primarily been evaluated in patients with moderate-to-severe cancer pain, and they effectively reduce pain in this population, with well-characterized adverse effects. Evidence was limited for several of the questions of interest, and the Expert Panel relied on consensus for these recommendations or noted that no recommendation could be made at this time. RECOMMENDATIONS: Opioids should be offered to patients with moderate-to-severe pain related to cancer or active cancer treatment unless contraindicated. Opioids should be initiated PRN (as needed) at the lowest possible dose to achieve acceptable analgesia and patient goals, with early assessment and frequent titration. For patients with a substance use disorder, clinicians should collaborate with a palliative care, pain, and/or substance use disorder specialist to determine the optimal approach to pain management. Opioid adverse effects should be monitored, and strategies are provided for prevention and management. Additional information is available at www.asco.org/supportive-care-guidelines .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews
Shea, B. J., Grimshaw, J. M., Wells, G. A., Boers, M., Andersson, N., Hamel, C., Porter, A. C., Tugwell, P., Moher, D., & Bouter, L. M. (2007) · BMC Medical Research Methodology · doi:10.1186/1471-2288-7-10 · Cited by 4,374
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697
Ferrell, B. R., Temel, J. S., Temin, S., Alesi, E. R., Balboni, T. A., Basch, E. M., Firn, J. I., Paice, J. A., Peppercorn, J. M., Phillips, T., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.1474 · Cited by 2,117
Self-citationUpdate on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis
van den Beuken-van Everdingen, M. H. J., Hochstenbach, L. M. J., Joosten, E. A. J., Tjan-Heijnen, V. C. G., & Janssen, D. J. A. (2016) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2015.12.340 · Cited by 1,663
Clinical Pharmacology of Tramadol
Grond, S., & Sablotzki, A. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443130-00004 · Cited by 1,282
Webster, L. R., & Webster, R. M. (2005) · Pain Medicine · doi:10.1111/j.1526-4637.2005.00072.x · Cited by 1,096
Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
Fallon, M., Giusti, R., Aielli, F., Hoskin, P., Rolke, R., Sharma, M., & Ripamonti, C. I. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy152 · Cited by 954
Schnipper, L. E., Davidson, N. E., Wollins, D. S., Tyne, C., Blayney, D. W., Blum, D., Dicker, A. P., Ganz, P. A., Hoverman, J. R., Langdon, R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6706 · Cited by 912
CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants
Bradford, L. D. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.2.229 · Cited by 773
Schnipper, L. E., Davidson, N. E., Wollins, D. S., Blayney, D. W., Dicker, A. P., Ganz, P. A., Hoverman, J. R., Langdon, R., Lyman, G. H., Meropol, N. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.2518 · Cited by 655
American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
Meropol, N. J., Schrag, D., Smith, T. J., Mulvey, T. M., Langdon, R. M., Blum, D., Ubel, P. A., & Schnipper, L. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1183 · Cited by 638
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Swarm, R. A., Paice, J. A., Anghelescu, D. L., Are, M., Bruce, J. Y., Buga, S., Chwistek, M., Cleeland, C., Craig, D., Gafford, E., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0038 · Cited by 621
Self-citationPatient-clinician communication: American Society of Clinical Oncology consensus guideline
Gilligan, T., Coyle, N., Frankel, R. M., Berry, D. L., Bohlke, K., Epstein, R. M., Finlay, E., Jackson, V. A., Lathan, C. S., Loprinzi, C. L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.2311 · Cited by 610
Self-citationPaice, J. A., Portenoy, R., Lacchetti, C., Campbell, T., Cheville, A., Citron, M., Constine, L. S., Cooper, A., Glare, P., Keefe, F., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.5206 · Cited by 599
Self-citationGomes, T., Juurlink, D. N., Antoniou, T., Mamdani, M. M., Paterson, J. M., & van den Brink, W. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002396 · Cited by 524
Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
Dusetzina, S. B., Winn, A. N., Abel, G. A., Huskamp, H. A., & Keating, N. L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.9123 · Cited by 500
Crews, K. R., Monte, A. A., Huddart, R., Caudle, K. E., Kharasch, E. D., Gaedigk, A., Dunnenberger, H. M., Leeder, J. S., Callaghan, J. T., Samer, C. F., et al. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2149 · Cited by 434
Alcohol-Related Deaths During the COVID-19 Pandemic
White, A. M., Castle, I.-J. P., Powell, P. A., Hingson, R. W., & Koob, G. F. (2022) · JAMA · doi:10.1001/jama.2022.4308 · Cited by 369
Mao, J. J., Ismaila, N., Bao, T., Barton, D., Ben-Arye, E., Garland, E. L., Greenlee, H., Leblanc, T., Lee, R. T., Lopez, A. M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.01357 · Cited by 359
Self-citationPatel, M. I., Lopez, A. M., Blackstock, W., Reeder-Hayes, K., Moushey, E. A., Phillips, J., & Tap, W. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00642 · Cited by 338
Larkin, P. J., Cherny, N. I., La Carpia, D., Guglielmo, M., Ostgathe, C., Scotté, F., & Ripamonti, C. I. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy148 · Cited by 273
Agnoli, A., Xing, G., Tancredi, D. J., Magnan, E., Jerant, A., & Fenton, J. J. (2021) · JAMA · doi:10.1001/jama.2021.11013 · Cited by 273
Fisch, M. J., Lee, J.-W., Weiss, M., Wagner, L. I., Chang, V. T., Cella, D., Manola, J. B., Minasian, L. M., McCaskill-Stevens, W., Mendoza, T. R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.2381 · Cited by 271
Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions
Streeter, S. B., Schwartzberg, L., Husain, N., & Johnsrud, M. (2011) · Journal of Oncology Practice · doi:10.1200/jop.2011.000316 · Cited by 248
Oliva, E. M., Bowe, T., Manhapra, A., Kertesz, S., Hah, J. M., Henderson, P., Robinson, A., Paik, M., Sandbrink, F., Gordon, A. J., et al. (2020) · BMJ · doi:10.1136/bmj.m283 · Cited by 240
Crockett, S. D., Greer, K. B., Heidelbaugh, J. J., Falck-Ytter, Y., Hanson, B. J., & Sultan, S. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.07.016 · Cited by 198
Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review
Mercadante, S., & Caraceni, A. (2011) · Palliative Medicine · doi:10.1177/0269216311406577 · Cited by 191
Self-citationShiffman, R. N., Michel, G., Rosenfeld, R. M., & Davidson, C. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000172 · Cited by 184
Racial Inequality in Prescription Opioid Receipt — Role of Individual Health Systems
Morden, N. E., Chyn, D., Wood, A., & Meara, E. (2021) · New England Journal of Medicine · doi:10.1056/nejmsa2034159 · Cited by 184
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain
Bandieri, E., Romero, M., Ripamonti, C. I., Artioli, F., Sichetti, D., Fanizza, C., Santini, D., Cavanna, L., Melotti, B., Conte, P. F., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.0733 · Cited by 181
Self-citationPregabalin and the Risk for Opioid-Related Death: A Nested Case–Control Study
Gomes, T., Greaves, S., van den Brink, W., Antoniou, T., Mamdani, M. M., Paterson, J. M., Martins, D., & Juurlink, D. N. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1136 · Cited by 165
Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients
Tiseo, P. J., Thaler, H. T., Lapin, J., et al. (1995) · Pain · doi:10.1016/0304-3959(94)00148-8 · Cited by 148
Portenoy, R. K., Foley, K. M., Stulman, J., Khan, E. A., Adelhardt, J., Layman, M., Cerbone, D. J., & Inturrisi, C. E. (1991) · Pain · doi:10.1016/0304-3959(91)90005-i · Cited by 115
US Trends in Opioid Access Among Patients With Poor Prognosis Cancer Near the End-of-Life
Enzinger, A. C., Ghosh, K., Keating, N. L., Cutler, D., Landrum, M. B., & Wright, A. A. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00476 · Cited by 114
Paice, J. A. (2018) · Cancer · doi:10.1002/cncr.31303 · Cited by 113
Self-citationPain Management for Patients With Advanced Cancer in the Opioid Epidemic Era
Dalal, S., & Bruera, E. D. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_100020 · Cited by 109
Self-citationTarumi, Y., Wilson, M. P., Szafran, O., & Spooner, G. R. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2012.02.008 · Cited by 108
A Systematic Review of Randomized Trials on the Effectiveness of Opioids for Cancer Pain
Koyyalagunta, L. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es39 · Cited by 102
Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer
Arthur, J. A., & Bruera, E. D. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0143-7 · Cited by 99
Self-citationYennurajalingam, S., Arthur, J. A., Reddy, S., Edwards, T., Lu, Z., de Moraes, A. R., Wilson, S. M., Erdoğan, E., Joy, M. P., Ethridge, S. D., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.6789 · Cited by 93
Self-citationOpioids and cancer pain: patients' needs and access challenges
Page, R., & Blanchard, E. (2019) · Journal of Oncology Practice · doi:10.1200/jop.19.00081 · Cited by 83 · cited 1×
“Primary care clinicians may be unwilling to continue prescribing these medications, deferring to the oncology team.(114) If there is an additive effect of new cancer pain on top of persistent noncancer pain, dose escalation in the face of already high doses of opioids may be restricted by tolerance and toxicity along…”
BackgroundRadbruch, L., Trottenberg, P., Elsner, F., Kaasa, S., & Caraceni, A. T. (2011) · Palliative Medicine · doi:10.1177/0269216310383739 · Cited by 77
Pask, S., Dell’Olio, M., Murtagh, F. E., & Boland, J. W. (2019) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2019.10.022 · Cited by 74
Azizoddin, D. R., Knoerl, R., Adam, R., Kessler, D., Tulsky, J. A., Edwards, R. R., & Enzinger, A. C. (2021) · Cancer · doi:10.1002/cncr.33532 · Cited by 72
MASCC recommendations on the management of constipation in patients with advanced cancer
Davies, A. N., Leach, C., Caponero, R., Dickman, A. R., Fuchs, D., Paice, J. A., & Emmanuel, A. V. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-05016-4 · Cited by 67
Self-citationPredicting Persistent Opioid Use, Abuse, and Toxicity Among Cancer Survivors
Vitzthum, L. K., Riviere, P. J., Sheridan, P. E., Nalawade, V. V., Deka, R., Furnish, T. J., Mell, L. K., Rose, B. S., Wallace, M. S., & Murphy, J. D. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz200 · Cited by 65
Reddy, A. S., Yennurajalingam, S., Pulivarthi, K., Palla, S. L., Wang, X., Kwon, J. H., Frisbee‐Hume, S. E., & Bruera, E. D. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0269 · Cited by 58
Self-citationBoland, J. W., Ziegler, L. E., Boland, E. G., McDermid, K., & Bennett, M. (2015) · Pain · doi:10.1097/j.pain.0000000000000306 · Cited by 57
DiPrete, B. L., Ranapurwala, S. I., Maierhofer, C., Fulcher, N., Chelminski, P. R., Ringwalt, C. L., Ives, T. J., Dasgupta, N., Go, V. F.-L., & Pence, B. W. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.9191 · Cited by 56
Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses
Mercadante, S., Gatti, A., Porzio, G., Presti, C. L., Aielli, F., Adile, C., & Casuccio, A. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.683112 · Cited by 55
Self-citationStone, P. C., & Minton, O. (2010) · Palliative Medicine · doi:10.1177/0269216310380763 · Cited by 55
The use of opioids in cancer patients with renal impairment—a systematic review
Sande, T. A., Laird, B. J. A., & Fallon, M. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3447-0 · Cited by 54
The Management of Opioid-Induced Nausea and Vomiting in Patients with Cancer: A Systematic Review
Sande, T. A., Laird, B. J. A., & Fallon, M. (2018) · Journal of Palliative Medicine · doi:10.1089/jpm.2018.0260 · Cited by 53
Prommer, E. (2011) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909111427029 · Cited by 51
A Systematic Review of Observational Studies on the Effectiveness of Opioid Therapy for Cancer Pain
Colson, J. D. (2011) · Pain Physician · doi:10.36076/ppj.2011/14/e85 · Cited by 49
Raptis, E., Vadalouca, A., Stavropoulou, E., Αrgyra, E., Melemeni, A., & Siafaka, I. (2013) · Pain Practice · doi:10.1111/papr.12045 · Cited by 49
Rauck, R. L., Reynolds, L. W., Geach, J., Bull, J., Stearns, L. J., Scherlis, M., Parikh, N., & Dillaha, L. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.683111 · Cited by 45
Klepstad, P., Kaasa, S., & Borchgrevink, P. C. (2011) · Palliative Medicine · doi:10.1177/0269216310386280 · Cited by 45
Framework for opioid stigma in cancer pain
Bulls, H. W., Chu, E., Goodin, B. R., Liebschutz, J. M., Wozniak, A. J., Schenker, Y., & Merlin, J. S. (2021) · Pain · doi:10.1097/j.pain.0000000000002343 · Cited by 45
Mercadante, S., Adile, C., Cuomo, A., Aielli, F., Cortegiani, A., Casuccio, A., & Porzio, G. (2015) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2015.05.016 · Cited by 44
Self-citationAgarwal, A., Roberts, A., Dusetzina, S., & Royce, T. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.2211 · Cited by 41
Vitzthum, L. K., Nalawade, V. V., Riviere, P. J., Sumner, W., Nelson, T. J., Mell, L. K., Furnish, T. J., Rose, B. S., Martínez, M. E., & Murphy, J. D. (2021) · JCO Oncology Practice · doi:10.1200/op.20.00773 · Cited by 40
MASCC antiemetics in advanced cancer updated guideline
Davis, M. P., Hui, D., Davies, A. N., Ripamonti, C. I., Capela, A., DeFeo, G., Fabbro, E. D., & Bruera, E. D. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06437-w · Cited by 40
Self-citationImplementation and enforcement of state opioid prescribing laws
Stone, E. M., Rutkow, L., Bicket, M. C., Barry, C. L., Alexander, G. C., & McGinty, E. E. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108107 · Cited by 39
Patient Patterns and Perspectives on Using Opioid Regimens for Chronic Cancer Pain
Wright, E. M., El-Jawahri, A. R., Temel, J. S., Carr, A. L., Safren, S. A., Park, E. R., Pirl, W. F., Bruera, E. D., & Traeger, L. N. (2019) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2019.02.023 · Cited by 36
Self-citationDavies, A. N., Leach, C., Butler, C., Gregory, A., Henshaw, S., Minton, O., Shorthose, K., & Batsari, K. M. (2020) · Pain · doi:10.1097/j.pain.0000000000002024 · Cited by 34
Schenker, Y., Hamm, M., Bulls, H. W., Merlin, J. S., Wasilko, R., Dawdani, A., Kenkre, B. N., Belin, S. C., & Sabik, L. M. (2021) · JCO Oncology Practice · doi:10.1200/op.20.01041 · Cited by 34
Bulls, H. W., Abdulhay, L. B., Orris, S. R., Goodin, B. R., Liebschutz, J. M., Wozniak, A. J., Merlin, J. S., & Schenker, Y. (2021) · Cancer · doi:10.1002/cncr.33639 · Cited by 33
Zecca, E., Brunelli, C., Centurioni, F., Manzoni, A., Pigni, A., & Caraceni, A. T. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.9504 · Cited by 32
Brown, J. H., Torres, H. P., Maddi, R. D., Williams, J. L., Dibaj, S. S., Liu, D., & Bruera, E. D. (2020) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2020.06.015 · Cited by 32
Self-citationMesgarpour, B., Griebler, U., Glechner, A., Kien, C., Strobelberger, M., Noord, M. V., & Michalek-Sauberer, A. (2013) · European Journal of Pain · doi:10.1002/j.1532-2149.2013.00401.x · Cited by 31
Hypogonadism associated with long-term opioid therapy: A systematic review
Birthi, P., Nagar, V. R., Nickerson, R. B., & Sloan, P. A. (2015) · Journal of Opioid Management · doi:10.5055/jom.2015.0274 · Cited by 26
The Opioid Rotation Ratio of Hydrocodone to Strong Opioids in Cancer Patients
Reddy, A. S., Yennurajalingam, S., DESAI, H. H., Reddy, S., la Cruz, M. G. D., Wu, J., Liu, D., Rodriguez, E. M., Waletich-Flemming, J. M., Shin, S. H., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0130 · Cited by 25
Self-citationRogríguez, D., Urrútia, G., Escobar, Y., Moyá, J., & González, M. M. (2015) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2015.1047554 · Cited by 23
Kosugi, T., Hamada, S., Takigawa, C., Shinozaki, K., Kunikane, H., Goto, F., Tanda, S., Shima, Y., Yomiya, K., Matoba, M., et al. (2013) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.07.006 · Cited by 23
Prescription Opioids Dispensed to Patients with Cancer with Bone Metastasis: 2011–2017
Zhang, H., Paice, J. A., Portenoy, R. K., Bruera, E. D., Reid, M. C., & Bao, Y. (2021) · The Oncologist · doi:10.1002/onco.13898 · Cited by 23
Self-citationHaumann, J., van Kuijk, S. M. J., Geurts, J. W., et al. (2017) · Pain Practice · doi:10.1111/papr.12609 · Cited by 22
Zhou, J., Wang, Y., & Jiang, G. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231763 · Cited by 20
Azhar, A., Kim, Y. J., Haider, A., Hui, D., Balankari, V. R., Epner, M., Park, M., Liu, D. D., Williams, J. L., Frisbee‐Hume, S. E., et al. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0583 · Cited by 19
Self-citationHui, D., Abdelghani, E., Chen, J., Dibaj, S., Zhukovsky, D. S., Dev, R., Tanco, K. C., Haider, A., Azhar, A., Reddy, A. S., et al. (2020) · Cancers · doi:10.3390/cancers12010214 · Cited by 15
Self-citationLee, K.-H., Kim, T. W., Kang, J.-H., Kim, J.-S., Ahn, J., Kim, S., Yun, H., Eum, Y.-J., Koh, S. A., Kim, M. K., et al. (2017) · 癌症:英文版 · doi:10.1186/s40880-017-0241-4 · Cited by 13
Has Declining Opioid Dispensing to Cancer Patients Been Tailored to Risk of Opioid Harms?
Townsend, T., Salz, T., Haffajee, R. L., Caram, M. E. V., Chino, F. L., & Bohnert, A. S. B. (2021) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2021.09.014 · Cited by 13
Medical Management of Opioid-Induced Constipation
Rao, V. L., Micić, D., & Davis, A. M. (2019) · JAMA · doi:10.1001/jama.2019.15852 · Cited by 11
Patterns of opioid analgesic use in the U.S., 2009 to 2018
Woods, C. M., Chai, G. P., Meyer, T. E., Staffa, J. A., & Pan, G. J. D. (2020) · Pain · doi:10.1097/j.pain.0000000000002101 · Cited by 11
Decreasing Trends in Opioid Prescribing on Discharge to Hospice Care
Furuno, J. P., Noble, B. N., Fromme, E. K., Hartung, D. M., Tjia, J., Lynn, M., & Teno, J. M. (2021) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2021.03.025 · Cited by 11
Is There a Role for 5-HT 3 Receptor Antagonists in the Treatment of Opioid-Induced Pruritus?
Rashid, S., Trivedi, D. D., Al-Shathir, M., Moulton, M., & Baumrucker, S. J. (2017) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909117736062 · Cited by 9
Patients’ Satisfaction with Breakthrough Cancer Pain Therapy: A Secondary Analysis of IOPS-MS Study
Mazzotta, M., Filetti, M., Piras, M., Mercadante, S., Marchetti, P., & Giusti, R. (2022) · Cancer Management and Research · doi:10.2147/cmar.s353036 · Cited by 8
Self-citationChallenges to Opioid Prescription Access among Patients with Advanced Cancer
Vidal, M., Reddy, A. S., Rodriguez, E. C., Park, M., Liu, D., & Bruera, E. D. (2019) · Journal of Palliative Medicine · doi:10.1089/jpm.2018.0577 · Cited by 7
Self-citation
Research works printed but not linked: 49
- World Health Organization, 2018, WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents
- Candy B, 2018, Cochrane Database Syst Rev, 6, CD006332
- 10.1177/0269216310392101 · doi:10.1177/0269216310392101
- Hadley G, 2013, Cochrane Database Syst Rev, 2013, CD010270
- 10.1136/bmjspcare-2021-003065 · doi:10.1136/bmjspcare-2021-003065
- Li Y, 2021, Cochrane Database Syst Rev, 8, CD011108
- 10.1016/j.jpainsymman.2017.10.017 · doi:10.1016/j.jpainsymman.2017.10.017
- Nicholson AB, 2017, Cochrane Database Syst Rev, 2, CD003971
- Schmidt-Hansen M, 2017, Cochrane Database Syst Rev, 8, CD003870
- Schmidt-Hansen M, 2015, Cochrane Database Syst Rev, 2015, CD009596
- Schuster M, 2018, Dtsch Arztebl Int, 115, 135
- Straube C, 2014, Cochrane Database Syst Rev, 2014, CD006601
- 10.4103/0973-1482.171368 · doi:10.4103/0973-1482.171368
- Wiffen PJ, 2014, Cochrane Database Syst Rev, 2014, CD011056
- Wiffen PJ, 2017, Cochrane Database Syst Rev, 5, CD012508
- Wiffen PJ, 2015, Cochrane Database Syst Rev, 2015, CD011460
- Wiffen PJ, 2017, Cochrane Database Syst Rev, 7, CD012592
- Wiffen PJ, 2016, Cochrane Database Syst Rev, 4, CD003868
- Zhang X, 2019, Pain Physician, 22, 331
- 10.1002/ejp.1548 · doi:10.1002/ejp.1548
- 10.1093/jjco/hyy046 · doi:10.1093/jjco/hyy046
- 10.1002/ejp.577 · doi:10.1002/ejp.577
- 10.21037/apm-20-2336 · doi:10.21037/apm-20-2336
- 10.1097/MD.0000000000015505 · doi:10.1097/md.0000000000015505
- 10.1016/j.jpainsymman.2016.05.022 · doi:10.1016/j.jpainsymman.2016.05.022
- 10.1634/theoncologist.2017-0225 · doi:10.1634/theoncologist.2017-0225
- World Health Organization, 2018, WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents
- Bruera E, 2022, Cancer Pain Treatment Selection
- Paice JA, 2022, Opioid Management
- Berlin J, 2020, Tex Med, 116, 29
- 10.1002/cncr.33326 · DOI
- US Department of Veterans Affairs, 2016, Opioid Taper Decision Tool. Washington, DC, US Department of Veterans Affairs
- 10.1177/0269216308088692 · doi:10.1177/0269216308088692
- 10.1097/AJP.0b013e3181929b4f · doi:10.1097/ajp.0b013e3181929b4f
- 10.1016/j.jpainsymman.2006.01.001 · doi:10.1016/j.jpainsymman.2006.01.001
- US Food and Drug Administration, 2013, Letter to Application Holders: ER/LA Opioid Analgesic Class Labeling Changes and Postmarketing Requirements. Silver Spring, MD, US Food and Drug Administration
- 10.1007/s40262-015-0345-4 · doi:10.1007/s40262-015-0345-4
- 10.1002/cncr.29688 · doi:10.1002/cncr.29688
- 10.1016/j.jpainsymman.2017.07.001 · doi:10.1016/j.jpainsymman.2017.07.001
- Rosielle D, 2022, Opioid Equianalgesic Tables Are Broken, Pallimed: A Hospice & Palliative Medicine Blog. Pallimed
- Centers for Disease Control, 2021, Drug Overdose Deaths in the US Top 100,000 Annually. Hyattsville, MD, CDC, National Center for Health Statistics
- 10.1016/j.jpainsymman.2020.11.033 · doi:10.1016/j.jpainsymman.2020.11.033
- American Cancer Society, 2022, Cancer Facts & Figures for African American/Black People 2022-2024
- American Cancer Society, 2021, Cancer Facts & Figures for Hispanic/Latino People 2021-2023
- 10.1056/NEJMp2115244 · doi:10.1056/nejmp2115244
- Marudhai S, 2020, Cureus, 12, e10813
- 10.4140/TCP.n.2015.221 · doi:10.4140/tcp.n.2015.221
- Gammel LB, 2022, Cureus, 14, e22356
- 10.1177/1049909110374454 · doi:10.1177/1049909110374454
Cited by
Palliative Care for Patients With Cancer: ASCO Guideline Update
Sanders, J. J., Temin, S., Ghoshal, A., Alesi, E. R., Ali, Z. V., Chauhan, C., Cleary, J. F., Epstein, A. S., Firn, J. I., Jones, J. A., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.24.00542 · Cited by 373
Calton, B. A., Nouri, S., Davila, C., Kotwal, A., Zapata, C., & Bischoff, K. E. (2023) · Cancers · doi:10.3390/cancers15215121 · Cited by 9
Yusufov, M., Pirl, W. F., Greer, J. A., Mazzola, E., Dalrymple, K. L., Tulsky, J. A., Braun, I. M., & McHugh, R. K. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-096546 · Cited by 1
Metadata
- Authors
- Paice, J. A., Bohlke, K., Barton, D., Craig, D. S., El-Jawahri, A., Hershman, D. L., Kong, L. R., Kurita, G. P., LeBlanc, T. W., Mercadante, S., Novick, K. L. M., Sedhom, R., Seigel, C., Stimmel, J., & Bruera, E.
- Venue
- Journal of Clinical Oncology
- Published
- 2023-02-01
- Volume
- 41
- Issue
- 4
- Pages
- 914-930
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W4310780757
- Cited by
- 304
- References
- 88
- FWCI
- 53.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.